Torsade de pointes.
Torsade de pointes
Torsade de pointes.
Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes
Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular Drugs
Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death.
Long QT syndromes and torsade de pointes.
Unique topographical distribution of M cells underlies reentrant mechanism of torsade de pointes in the long-QT syndrome
Taking the "idio"out of "idiosyncratic": predicting torsades de pointes.
Treatment of torsade de pointes with magnesium sulfate.
Risk of torsades de pointes from oral erythromycin with concomitant carbimazole (methimazole) administration
Drug induced QT prolongation and torsades de pointes
Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodaro...